These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2460883

  • 1. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG, Faull KF, Pfefferbaum A.
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract] [Full Text] [Related]

  • 2. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
    Jibson M, Faull KF, Csernansky JG.
    Biol Psychiatry; 1990 Oct 01; 28(7):595-602. PubMed ID: 1699614
    [Abstract] [Full Text] [Related]

  • 3. Central noradrenergic function in man: vanillylmandelic acid in CSF.
    Jimerson DC, Gordon EK, Post RM, Goodwin FK.
    Brain Res; 1975 Dec 05; 99(2):434-9. PubMed ID: 1182564
    [No Abstract] [Full Text] [Related]

  • 4. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L, Asberg M, Lantto O, Scalia-Tomba GP, Träskman-Bendz L, Tybring G.
    Psychiatry Res; 1982 Feb 05; 6(1):77-83. PubMed ID: 6173891
    [Abstract] [Full Text] [Related]

  • 5. Corrections to a 1980 article on CSF monoamine metabolites.
    Faull KF, Berger PA, Kilkowski J, Anderson PJ, Kraemer H, Davis KL, Barchas JD.
    Am J Psychiatry; 1989 Jan 05; 146(1):118. PubMed ID: 2463774
    [No Abstract] [Full Text] [Related]

  • 6. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ, Manji HK.
    Arch Gen Psychiatry; 1993 Aug 05; 50(8):653-6. PubMed ID: 7688211
    [No Abstract] [Full Text] [Related]

  • 7. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample.
    Faustman WO, Ringo DL, Faull KF.
    Br J Psychiatry; 1993 Oct 05; 163():519-21. PubMed ID: 7504565
    [Abstract] [Full Text] [Related]

  • 8. Genetic studies of CSF monoamine metabolites.
    Sedvall G, Iselius L, Nybäck H, Oreland L, Oxenstierna G, Ross SB, Wiesel FA.
    Adv Biochem Psychopharmacol; 1984 Oct 05; 39():79-85. PubMed ID: 6205565
    [No Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid correlates of suicide attempts and aggression.
    Brown GL, Goodwin FK.
    Ann N Y Acad Sci; 1986 Oct 05; 487():175-88. PubMed ID: 2436532
    [No Abstract] [Full Text] [Related]

  • 10. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H.
    Psychiatry Res; 1980 Oct 05; 3(2):211-23. PubMed ID: 6171840
    [Abstract] [Full Text] [Related]

  • 11. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
    Jennings WS, Schulz SC, Narasimhachari N, Hamer RM, Friedel RO.
    Psychiatry Res; 1985 Oct 05; 16(2):87-94. PubMed ID: 2415997
    [Abstract] [Full Text] [Related]

  • 12. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D.
    Psychol Rep; 1991 Feb 05; 68(1):146. PubMed ID: 1709746
    [No Abstract] [Full Text] [Related]

  • 13. Acid metabolites and precursor amino acids of 5-hydroxytryptamine and dopamine in affective and other psychiatric disorders.
    Korf J, van den Burg W, van den Hoofdakker RH.
    Psychiatr Clin (Basel); 1983 Feb 05; 16(1):1-16. PubMed ID: 6189146
    [Abstract] [Full Text] [Related]

  • 14. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C, Bjerkenstedt L, Grimm VE, Sedvall G.
    Psychopharmacology (Berl); 1979 Aug 08; 64(2):131-4. PubMed ID: 115032
    [Abstract] [Full Text] [Related]

  • 15. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF, Cohen DJ, Shaywitz BA, Caparulo BK, Heninger GR, Bowers MB.
    Arch Gen Psychiatry; 1980 Jun 08; 37(6):677-81. PubMed ID: 6155891
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW, Ebert MH, van Kammen DP, Post RM, Goodwin FK.
    Biol Psychiatry; 1983 Nov 08; 18(11):1287-99. PubMed ID: 6197100
    [Abstract] [Full Text] [Related]

  • 17. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF, Bowers MB, Sturges JS.
    Am J Psychiatry; 1981 Apr 08; 138(4):472-7. PubMed ID: 6163366
    [Abstract] [Full Text] [Related]

  • 18. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB, Starkstein SE, Votypka V, Parikh RM, Price TR, Robinson RG.
    J Neuropsychiatry Clin Neurosci; 1992 Apr 08; 4(4):440-2. PubMed ID: 1384852
    [Abstract] [Full Text] [Related]

  • 19. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ.
    Am J Psychiatry; 1984 Dec 08; 141(12):1533-40. PubMed ID: 6209989
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
    Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM.
    Psychiatry Res; 1985 Aug 08; 15(4):281-92. PubMed ID: 2415996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.